Average Co-Inventor Count = 3.53
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (22 from 1,829 patents)
2. Sunesis Pharmaceuticals, Inc. (11 from 63 patents)
3. Denali Therapeutics Inc. (9 from 52 patents)
4. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
5. Schering-Plough Corporation (2 from 28 patents)
6. Other (1 from 832,912 patents)
47 patents:
1. 12497387 - Process for the preparation of pyrimidinyl-4-aminopyrazole compounds
2. 11999750 - Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
3. 11851433 - Compounds, compositions and methods
4. 11834438 - Process for the preparation of pyrimidinyl-4-aminopyrazole compounds
5. 11427571 - Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
6. 11174262 - Compounds, compositions and methods
7. 10851088 - Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
8. 10709692 - Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1)
9. 10370361 - Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production
10. 9969730 - Stable SNS-595 compositions and methods of preparation
11. 9839630 - Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
12. 9676774 - Compounds and compositions for treatment of cancer
13. 9469635 - Stable SNS-595 compositions and methods of preparation
14. 8802719 - [object Object]
15. 8765954 - 1,8-naphthyridine compounds for the treatment of cancer